ANI Pharmaceuticals, Inc.: Drug Recall
Recall #D-0568-2022 · 02/15/2022
Class II: Risk
Recall Details
- Recall Number
- D-0568-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ANI Pharmaceuticals, Inc.
- Status
- Terminated
- Date Initiated
- 02/15/2022
- Location
- Baudette, MN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,477 bottles
Reason for Recall
cGMP Deviations
Product Description
Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.
Distribution Pattern
Nationwide within the United States
Other Recalls by ANI Pharmaceuticals, Inc.
- Class II: Risk 02/15/2022
- Class II: Risk 02/15/2022
- Class II: Risk 02/15/2022
- Class II: Risk 02/15/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.